Trials / Unknown
UnknownNCT06078722
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (estimated)
- Sponsor
- Kazakh Association of Internal Medicine Specialists · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The goal of this observational study is to learn the effectiveness and safety of the use of Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the pathogenetic therapy of metabolic-associated fatty liver disease (MAFLD)
Conditions
Timeline
- Start date
- 2023-02-08
- Primary completion
- 2025-02-08
- Completion
- 2025-02-08
- First posted
- 2023-10-12
- Last updated
- 2023-10-12
Locations
7 sites across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT06078722. Inclusion in this directory is not an endorsement.